Pharmacokinetic behaviour of the chemoprotectants BNP7787 and mesna after an i.v. bolus injection in rats

por Verschraagen, M, Boven, E, Torun, E, Erkelens, C A M, Hausheer, F H, van der Vijgh, W J F
Publicado 2004

Prognostic role of topoisomerase-IIα in advanced ovarian cancer patients

por Ferrandina, G, Petrillo, M, Carbone, A, Zannoni, G, Martinelli, E, Prisco, M, Pignata, S, Breda, E, Savarese, A, Scambia, G
Publicado 2008

Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model

por Bozec, A, Sudaka, A, Fischel, J-L, Brunstein, M-C, Etienne-Grimaldi, M-C, Milano, G
Publicado 2008

Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer: results of secondary end points analyses

por Sultana, A, Tudur Smith, C, Cunningham, D, Starling, N, Neoptolemos, J P, Ghaneh, P
Publicado 2008

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

por Diaz, M, Kim, J J, Albero, G, de Sanjosé, S, Clifford, G, Bosch, F X, Goldie, S J
Publicado 2008

Do women ⩾50 years of age need as much screening as women <50 years after they have had negative screening results?

por Armaroli, P, Gallo, F, Bellomi, A, Ciatto, S, Consonni, D, Davi, D, Giorgi-Rossi, P, Iossa, A, Mancini, E, Naldoni, C, Polla, E, Ronco, G, Serafini, M, Vergini, V, Zanier, L, Zappa, M, Segnan, N
Publicado 2008

The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer

por de Graeff, P, Crijns, A P G, ten Hoor, K A, Klip, H G, Hollema, H, Oien, K, Bartlett, J M, Wisman, G B A, de Bock, G H, de Vries, E G E, de Jong, S, van der Zee, A G J
Publicado 2008

Phase III randomised trial of doxorubicin-based chemotherapy compared with platinum-based chemotherapy in small-cell lung cancer

por Baka, S, Califano, R, Ferraldeschi, R, Aschroft, L, Thatcher, N, Taylor, P, Faivre-Finn, C, Blackhall, F, Lorigan, P
Publicado 2008

Changes in subcellular localisation of MI-ER1α, a novel oestrogen receptor-α interacting protein, is associated with breast cancer progression

por McCarthy, P L, Mercer, F C, Savicky, M W J, Carter, B A, Paterno, G D, Gillespie, L L
Publicado 2008

A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer

por Lee, J-L, Kang, Y-K, Kang, H J, Lee, K-H, Zang, D Y, Ryoo, B-Y, Kim, J G, Park, S R, Kang, W K, Shin, D B, Ryu, M-H, Chang, H M, Kim, T-W, Baek, J H, Min, Y J
Publicado 2008

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease

por Helms, M W, Kemming, D, Pospisil, H, Vogt, U, Buerger, H, Korsching, E, Liedtke, C, Schlotter, C M, Wang, A, Chan, S Y, Brandt, B H
Publicado 2008

Body size and the risk of biliary tract cancer: a population-based study in China

por Hsing, A W, Sakoda, L C, Rashid, A, Chen, J, Shen, M C, Han, T Q, Wang, B S, Gao, Y T
Publicado 2008

Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer

por Senapati, S, Chaturvedi, P, Sharma, P, Venkatraman, G, Meza, J L, El-Rifai, W, Roy, H K, Batra, S K
Publicado 2008

Estimation of renal function and its potential impact on carboplatin dosing in children with cancer

por Chinnaswamy, G, Cole, M, Boddy, A V, Keir, M, Price, L, Parry, A, English, M, Veal, G J
Publicado 2008

A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate

por Scandlyn, M J, Stuart, E C, Somers-Edgar, T J, Menzies, A R, Rosengren, R J
Publicado 2008

p53-independent mechanisms regulate the P2-MDM2 promoter in adult astrocytic tumours

por Dimitriadi, M, Poulogiannis, G, Liu, L, Bäcklund, L M, Pearson, D M, Ichimura, K, Collins, V P
Publicado 2008

Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel

por Oikonomopoulou, K, Li, L, Zheng, Y, Simon, I, Wolfert, R L, Valik, D, Nekulova, M, Simickova, M, Frgala, T, Diamandis, E P
Publicado 2008

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma

por Fens, M H A M, Hill, K J, Issa, J, Ashton, S E, Westwood, F R, Blakey, D C, Storm, G, Ryan, A J, Schiffelers, R M
Publicado 2008

CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype

por Helsby, N A, Lo, W-Y, Sharples, K, Riley, G, Murray, M, Spells, K, Dzhelai, M, Simpson, A, Findlay, M
Publicado 2008

Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?

por Catalano, V, Graziano, F, Santini, D, D'Emidio, S, Baldelli, A M, Rossi, D, Vincenzi, B, Giordani, P, Alessandroni, P, Testa, E, Tonini, G, Catalano, G
Publicado 2008